Founders Capital Management Greenwich Life Sciences, Inc. Transaction History
Founders Capital Management
- $164 Million
- Q3 2024
A detailed history of Founders Capital Management transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Founders Capital Management holds 500 shares of GLSI stock, worth $6,105. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$6,105
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GLSI
# of Institutions
38Shares Held
1.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$3.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA274KShares$3.34 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA134KShares$1.63 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.06 Million0.01% of portfolio
-
Northern Trust Corp Chicago, IL74.5KShares$909,6450.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $157M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...